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Abstract: Background: The emergence of a novel strain of pandemic influenza (pH1N1) in 2009 presented significant 
challenges to health care facilities worldwide. In our academic community medical center in suburban Philadelphia, we 
noted our first pH1N1 diagnosis in September 2009. We sought to assess the impact of pH1N1 disease on our hospitalized 
patient population. 
Methods: We prospectively collected clinical and epidemiological data on 29 consecutive patients that were admitted to 
our hospital with a primary or secondary diagnosis of influenza from October 1-November 30, 2009. Data were obtained 
through care of the patients and chart review. 
Results: Prominent symptoms on admission included fever, hypoxia, cough, myalgias, and diarrhea, with leukocytosis and 
neutrophilia. Pre-existing medical conditions included asthma, pregnancy, immunosuppressive therapy, and sickle cell 
disease. All but 5 of the patients were under 60 years of age. Three patients had culture-documented bacterial or 
mycoplasma infections. All but two of the patients received oseltamivir. Six required admission to the intensive care unit 
but only one patient died. 
Conclusions: Our population of hospitalized patients with novel pH1N1 influenza demonstrated many of the features that 
have been associated with pH1N1 disease in other populations. Most of the patients were women and none of the patients 
died directly as a complication of influenza. We observed a cluster of patients with a tetrad of features comprising a 
history of asthma, obesity, female gender, and African-American race. Individuals with this constellation of factors should 
be specifically targeted for pH1N1 vaccination. 
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BACKGROUND 
  Infection with influenza viruses can result in diverse 
clinical manifestations that are affected by the nature of the 
viral genome and host-specific factors, such as co-morbid 
conditions and pre-existing immunity. In 2009, an influenza 
A virus (pH1N1) began circulating that was distinct from 
prior influenza strains [1-5]. Clinical manifestations of the 
pH1N1 infection were notable for an increased risk of severe 
pneumonia in children over age 5 and adults under age 65 
[1,6-10]. Among older adults (age  65), the risk of severe 
disease was lower than with seasonal influenza. This may be 
due to weakly protective immunity against the virus obtained 
during remote exposure to influenza strains similar to 
pH1N1 [11]. The presenting symptoms of pH1N1 were 
similar to those of seasonal influenza and included fever, 
cough, sore throat, headache, and myalgias, but with an 
increased prevalence of gastrointestinal symptoms, 
especially diarrhea [2,4,12,13]. 
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  The pH1N1 influenza was associated with a wide 
spectrum of disease intensity [5]. In contrast to the original 
reports of severe and fatal disease, prospective studies 
demonstrated seroconversion in asymptomatic or only mildly 
asymptomatic individuals [14,15]. Many risk factors for 
severe pH1N1 influenza were identified that are similar to 
the risk factors for severe seasonal influenza. These include 
asthma, chronic obstructive pulmonary disease, diabetes, 
neurological disease, cardivascular disease, pregnancy, 
cancer, kidney disease, sickle cell disease, and 
immunosuppression [7,9,16-26]. Clinical features that 
correlated with severe disease included pulmonary infiltrates, 
hypoxia, shortness of breath, cyanosis, elevated creatinine, 
and leukopenia [7,9,10,20,27-29]. Worse outcomes were 
observed in patients if oseltamivir treatment was delayed 
[7,20,30]. The majority of these associations were identified 
in large epidemiological studies. 
  In the Fall of 2009, we observed an upsurge of cases that 
had a clinical and/or laboratory diagnosis of pH1N1 and 
were admitted to our academic community medical center. 
We conducted a prospective observational study, collecting 
epidemiological and clinical data on the 29 cases of pH1N1 20    The Open Respiratory Medicine Journal, 2011, Volume 5  Bergman et al. 
admitted to the adult medical service at LMC during October 
1 and November 30, 2009. 
METHODS 
  The setting for the study, the Lankenau Medical Center 
(LMC), is a 331-bed, academic community hospital situated 
in Wynnewood, Pennsylvania, a suburb adjacent to 
Philadelphia. LMC serves a diverse suburban and urban 
adult patient population from Philadelphia and the 
neighboring suburbs, but does not serve a substantial 
inpatient pediatric population. In 2009, LMC had 20,550 
hospital discharges. LMC is academically affiliated with the 
Thomas Jefferson University and has residency and 
fellowship training programs in medicine and surgery. 
  The study was conducted over an 8 week period from 
October 1 to November 30, 2009. Hospitalization was 
defined as being admitted to the inpatient service for greater 
than 24 hours. Patients were identified either because they 
were being cared for by one of the authors of the study (HB, 
LLL, JS) or because the LMC clinical laboratory reported 
positive pH1N1 testing results on a hospitalized patient. 
Subjects were considered suitable for inclusion in our study 
if they tested positive for the nasopharyngeal swab - rapid 
influenza diagnostic test (RIDT). Positive influenza A 
RIDTs were considered indicative of infection with pH1N1, 
which was the prevalent influenza strain during the study 
period [31]. Swabs were analyzed at the LMC laboratory. 
RT-PCR tests were performed by the Bureau of 
Laboratories, Pennsylvania Department of Health (Exton, 
PA). Additional subjects were included if considered 
probable pH1N1 infections, in which the clinical suspicion 
was high, the nasopharyngeal swab was negative, the RT-
PCR test was not obtained, and no other organism was 
identified. We collected and analyzed clinical and 
epidemiological data on a total of 29 patients, using a 
combination of physician-patient contact and chart review. 
The study was conducted as a Quality Improvement 
Initiative, to assess the impact of pH1Nq influenza on the 
LMC inpatient population. 
RESULTS 
  At LMC, the first positive RIDT in an adult ( 18 years 
of age) was obtained on August 3, 2009. A total of 4 positive 
patients were identified in August, 2009, and 11 cases were 
identified in September, indicating that we were in the early 
stages of the 2009 pH1N1 epidemic (Fig. 1). From October 1 
to November 30, 2009, we conducted a prospective 
observational study of patients with a diagnosis of influenza 
who were admitted to the hospital. In October and 
November,  2009, 166 and 73 patients tested positive for 
influenza, respectively (Fig. 1). This was followed by an 
abrupt drop-off in cases in December, during which we had 
only 5 positive test results. Thus, the timing of our study 
coincided with the peak of the 2009 influenza season at 
LMC. 
  The characteristics of the patients in our study are given 
in Table 1. 25 subjects (86%) were positive by the RIDT 
test, and 2 (7%) were negative for the RIDT, but positive by 
the RT-PCR test. Two additional patients (7%) were   
 
considered highly probable pH1N1 influenza. They were 
RIDT-negative, but had clinical findings strongly suggestive 
of influenza, including fever, sore throat, myalgias, and 
cough. In addition to suspected or RIDT-diagnosed influ-
enza, the admission diagnoses (Fig. 2) included asthma 
exacerbation (7 [24%]), pneumonia (7 [24%]), cardio-
vascular complications (5 [17%]) and sickle cell crisis (2, 
[7%]). One patient each had a diagnosis of gastrointestinal 
bleed, diabetic ketoacidosis, diarrhea with dehydration, and 
systemic inflammatory response syndrome. Patients ranged 
in age between 19-79 years (mean 47.1 years [median 47 
years]) (Fig. 3). Virtually all of the admitted patients were 
female (25 [86%]). Sixteen (55%) were African-American 
(n=16). The most common co-morbid condition was obesity 
(defined as a body mass index (BMI) > 30) in 17 (59%). 
Seven (24%) of these patients also met the definition for 
morbid obesity (BMI > 40). Thirteen (45%) the patients had 
asthma and 9 (31%) smoked tobacco. Three patients were 
pregnant (26 weeks, 32 weeks, and 1 day post-partum), and 
two of these had asthma. Two of the patients had sickle cell 
disease and one was undergoing therapy for breast cancer. 
Seven of our patients (24%) had a tetrad of features: a 
history of asthma, obesity, female gender, and African-
American case. 
 
Fig. (1). Positive RIDT results for adult patients (age >= 18 years of 
age) at the Lankenau Medical Center, August-December 2009. 
  Patients presented to the hospital within 1-14 days of 
their initial symptoms (mean 4.2 days, median 3 days). The 
symptoms that were typical of those reported by others for 
pH1N1 influenza include cough (27 [93%]), shortness of 
breath (24 [83%]), subjective fever (23 [79%]), myalgias (19 
[66%]), sore throat (10 [34%]), diarrhea (7/29, 24%), and 
headache (6/29, 21%). Temperatures on admission ranged 
from 96.3º F - 103.7º F (35.7º C – 39.8º C), with a mean 
temperature of 99.5º F (37.5º C). Chest radiography showed 
infiltrates suggestive of pneumonia in 10 patients (34%). 
Hypoxia, defined as an O2 sat < 93% in room air or as a 
requirement for supplemental O2, was observed in 12 
patients (41%) and in all but one of the patients with lung 
infiltrates (9 [31%]). Ten patients (34%) had leukocytosis 
(>10,000) with a predominance of neutrophils (44-97%, 
mean 76%). Additional microbiological isolates were 
obtained in 3 patients (2 with M.  pneumoniae, 1 with P. 
aeruginosa). 
  All but two of the patients received oseltamivir at 
standard doses (75 mg BID). One of the exceptions   
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Table 1.  Patient Characteristics 
 
Age, Years   
Mean (SD)  47.1 (16.6) 
Median (range)  47 (19-79) 
Gender, n (%)   
Female 25  (86) 
Male 4  (14) 
Comorbidities, n (%)   
Obesity (BMI > 30)  17 (59) 
Morbid obesity (BMI >40)  7 (24) 
Asthma 13  (45) 
Tobacco use  9 (31) 
Sickle cell disease  2 (6) 
Chemotherapy 1  (3) 
Pregnancy 3  (10) 
Presenting symptoms, n (%)   
Cough 27  (93) 
Dyspnea 24  (83) 
Subjective fever  23 (79) 
Myalgias 19  (66) 
Sore throat  10 (34) 
Diarrhea 7  (24) 
Clinical findings   
Temp on arrival to ED   
 Mean  99.6º F, 37.6º C 
 Median (range)  99.5º F (96.3º-103.7º F) 
37.5º C (35.7º-39.8º C) 
Hypoxia (O2 sat < 93%), n (%)  12 (41) 
Pulmonary infiltrates, n (%)  9 (31) 
Leukocytosis (> 10,000/l), n (%)  10 (34) 
Additional diagnosed  
infection, n (%) 
3 (10)  
(2 M. pneumoniae, 1 P. aeruginosa) 
Treatment and disposition, n (%) 
Oseltamivir 27  (93) 
ICU 6  (21) 
Death 1  (3) 
Discharge 28  (97) 
 
presented with renal insufficiency and had pH1N1 infection 
as a secondary diagnosis. The other had an outpatient 
diagnosis of pH1N1 and received a full course of Tamiflu, 
but was then admitted with post-influenza pneumonia. Six of 
the patients (21%) were admitted to the ICU and 5 (17%) 
had pulmonary infiltrates and hypoxia on admission. Both 
patients with sickle cell disease had pulmonary infiltrates 
and one required mechanical ventilation in the ICU. Another 
patient was transferred to the ICU with diabetic ketoacidosis. 
The one patient who died was admitted to the ICU with 
disseminated intravascular coagulopathy and a massive 
gastrointestinal hemorrhage that lead to a pulseless cardiac 
activity arrest and death. The other patients survived and 
were eventually discharged to home. 
 
Fig. (2). Ages of the patients admitted to the Lankenau Medical 
Center with a diagnosis of pH1N1 influenza, October and 
November, 2009. 
 
Fig. (3). Primary admission diagnoses of the study population. 
DISCUSSION 
  We conducted a prospective observational study of cases 
of pH1N1 influenza admitted to the LMC during the peak of 
our 2009 epidemic. Studies have been published that 
describe a diversity of populations affected by the pH1N1 
influenza outbreak, but ours is the first to focus on an 
inpatient population at a single North American academic 
community medical center. The impact of pH1N1 influenza 
on local populations may be distinct due to regional, facility-
dependent, and population-specific effects. For instance, 
indigenous populations in New Zealand and North America 
[8,32,33] had a disproportionate incidence of severe disease, 
as did male patients in one study in China [34]. 
  Our study was notable for 7 of the patients presenting 
with a tetrad of features that comprised a history of asthma, 
obesity, female gender, and African-American race. Each of 
the patients with the tetrad had mild-moderate hypoxia, 
although none of them required transfer to the ICU. Obesity 
has been associated with severe pH1N1 influenza, although 
it had not previously been linked to complicated seasonal 
influenza. Asthma has been established as an independent 
risk factor for complications of seasonal and pH1N1 
influenza [3,18,23,25,34-37]. Female gender and African-
American race have not independently been associated with 
higher rates of complications of pH1N1, although in one 
survey of hospital admissions in Wisconsin, African-22    The Open Respiratory Medicine Journal, 2011, Volume 5  Bergman et al. 
American patients were disproportionately affected by 
pH1N1 [38]. 
  Our population of hospitalized patients was affected by a 
broad spectrum of factors that have been associated with 
severe seasonal and pH1N1 influenza, including pregnancy, 
cardiac disease, renal insufficiency, and cancer therapy-
related immunosuppression. Upon admission, findings of 
pulmonary infiltrates, diarrhea, and neutrophilia were quite 
common. Admission temperatures were varied, including 
mild hypothermia and fevers, but did not correlate with any 
other clinical variables. Most of the patients were under 60 
years of age, consistent with observations in other studies 
and the finding that many individuals over 60 have a 
persisting immunoreactivity with pH1N1 antigens [11], 
although our group of 4 patients over 70 was atypical, 
compared to other studies. Only three of the subjects had an 
additional microbiological diagnosis. Despite the need for 
hospitalization, most of the patients were discharged to 
home, and the only observed death was not directly 
attributable to influenza. 
CONCLUSION 
  In summary, our study of patients admitted to our 
academic medical center with a diagnosis of pH1N1 
influenza has identified a novel tetrad of features that may 
indicate particular susceptibility to severe pH1N1 influenza, 
including a history of asthma, obesity, female gender, and 
African-American race. Individuals with this constellation of 
factors should be specifically targeted for pH1N1 
vaccination. 
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